.png)
The global Hematuria Treatment market size was valued at USD 1.17 billion in 2025 and is expected to reach USD 1.47 billion by 2033, at a CAGR of 2.90% during the forecast period
The market growth is largely fueled by the increasing prevalence of underlying conditions such as urinary tract infections, kidney stones, and bladder cancer, along with growing awareness and early diagnosis of urological disorders, leading to higher demand for effective treatment options
Furthermore, rising advancements in diagnostic techniques, improved access to healthcare services, and increasing demand for targeted and minimally invasive treatment solutions are establishing hematuria management as a critical component of urological care. These converging factors are accelerating the adoption of treatment solutions, thereby significantly boosting the industry's growth